FMP
Enter
API Tools
Extras
Malachite Innovations, Inc.
VBIO
OTC
Inactive Equity
Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.
0.39 USD
0.04 (10.26%)
Valuation Date:
Dec 31, 1969 7:00 PM
Share Price on Valuation Date
$0.39
Stock Beta
4.113756
Shares Outstanding
0
